MYOZ2 (Calsarcin-1) Gene Mutation Analysis
The MYOZ2 gene that is located in the long (q) arm of chromosome 4 at position 26 encodes for the Calsarcin-1 muscle protein. The Calsarcin-1 isoform is expressed in cardiac muscle and slow-twitch skeletal muscle. It serves as an intracellular binding protein to tether calcineurin to alpha-actinin, gamma-filamin, TCAP/telethonin and LDB3/ZASP at Z-discs. It plays an important role in the modulation of calcineurin signaling and inhibits a pathological cardiac hypertrophic response.
Mutations in this gene cause familial hypertrophic cardiomyopathy type 16, a hereditary heart disorder. Familial hypertrophic cardiomyopathy (FHCM) is typically inherited as an autosomal dominant disease characterized by left ventricular (LV) hypertrophy (thickening) associated with non-dilated ventricular chambers. Pathological features include myocardial fiber hypertrophy, disorganized myocardial cells, interstitial fibrosis and thickened intra-myocardial coronary vessels.
The majority of FHCM patients are asymptomatic. Only about 25% develop symptom such as dyspnea, syncope, collapse, palpitations, and chest pain. The disorder has inter- and intra-familial variability ranging from benign to malignant forms that have a high risk of cardiac failure and sudden cardiac death. FHCM is the most common cause of sudden cardiac death in young people with an estimated prevalence of 1:500 in the general adult population. The majority of the mutations in HCM are missense, insertion/deletion and frame-shift mutations. Mutations in MYOZ2 account for less than 1% of FHCM cases.
- Aids in the diagnosis of familial hypertrophic cardiomyopathy
- Carrier screening for relatives and those with the family history
- Prenatal carrier screening for those with the family history
Negative for mutations analyzed (No pathogenic variant or mutation detected)
Whole blood (EDTA).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Circ Res. 2007;100: 766-8. [PMID: 17347475]
- Cardiovasc Res. 2013;97: 44-54. [PMID: 22987565]
- Cardiovasc Diagn Ther. 2019; 9: S388-S415. [PMID: 20869644]
- Heart Fail Rev. 2019;24:439-459. [PMID: 30852773]
- Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/MYOZ2#